Insiders · ORGO

ORGO insider transactions

Organogenesis Holdings Inc. (ORGO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ORGO

• 1d
  Chief Commercial Officer Grow Brian exercised 958 shares at a strike of $1.24, increasing direct ownership by 0.11% to 900,682 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 45d
  Director Leibowitz Arthur S bought $13,405 worth of shares (5,000 units at $2.68), increasing direct ownership by 2% to 291,014 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 45d
  Director Driscoll Michael Joseph bought $26,688 worth of shares (10,000 units at $2.67), increasing direct ownership by 5% to 225,707 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 53d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 700 shares, decreasing direct ownership by 0.25% to 275,524 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Chief Admin. and Legal Officer Freedman Lori was granted 245,905 shares and covered exercise/tax liability with 14,267 shares, increasing direct ownership by 29% to 1,023,355 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Vice President, Strategy Cavorsi Robert was granted 110,040 shares and covered exercise/tax liability with 5,432 shares, increasing direct ownership by 61% to 276,115 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Chief Commercial Officer Grow Brian was granted 282,705 shares and covered exercise/tax liability with 11,768 shares, increasing direct ownership by 43% to 899,355 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Chief Financial Officer Francisco David covered exercise/tax liability with 14,541 shares and was granted 238,914 shares, increasing direct ownership by 44% to 731,020 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Chief Operating Officer Bilbo Patrick was granted 259,549 shares and covered exercise/tax liability with 16,212 shares, increasing direct ownership by 28% to 1,127,985 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  President and CEO Gillheeney Gary S. was granted 1,077,593 shares and covered exercise/tax liability with 90,398 shares, increasing direct ownership by 30% to 4,231,112 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Driscoll Michael Joseph was granted 48,828 shares, increasing direct ownership by 29% to 215,707 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Giacomin Jon L was granted 48,828 shares, increasing direct ownership by 25% to 241,026 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Leibowitz Arthur S was granted 48,828 shares, increasing direct ownership by 21% to 286,014 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Vice President, Health Policy Montecalvo Antonio S. covered exercise/tax liability with 3,741 shares and was granted 51,843 shares, increasing direct ownership by 27% to 226,163 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Quintero Gilberto was granted 48,828 shares, increasing direct ownership by 26% to 239,073 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Duraibabu Prathyusha was granted 48,828 shares, increasing direct ownership by 25% to 247,047 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Lustig Garrett was granted 48,828 shares, increasing direct ownership by 63% to 125,742 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 64d
  Director Korfin Michele Ilene was granted 48,828 shares, increasing direct ownership by 26% to 239,073 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Chief Financial Officer Francisco David covered exercise/tax liability with 52,448 shares, decreasing direct ownership by 9% to 506,647 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Chief Operating Officer Bilbo Patrick covered exercise/tax liability with 64,414 shares, decreasing direct ownership by 7% to 884,648 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 17,658 shares, decreasing direct ownership by 9% to 171,507 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Chief Admin. and Legal Officer Freedman Lori covered exercise/tax liability with 54,742 shares, decreasing direct ownership by 6% to 791,717 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  President and CEO Gillheeney Gary S. covered exercise/tax liability with 271,406 shares, decreasing direct ownership by 8% to 3,243,917 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Chief Commercial Officer Grow Brian covered exercise/tax liability with 43,959 shares, decreasing direct ownership by 7% to 628,418 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 66d
  Vice President, Health Policy Montecalvo Antonio S. covered exercise/tax liability with 18,619 shares, decreasing direct ownership by 9% to 178,061 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 128d
  Director Nussdorf Glenn H sold $1,027,060 worth of shares (200,000 units at $5.14), decreasing direct ownership by 7% to 2,565,591 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 150d
  Director Nussdorf Glenn H sold $1,592,120 worth of shares (300,000 units at $5.31), decreasing direct ownership by 10% to 2,765,591 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 173d
  Director Nussdorf Glenn H bought $1,096,039 worth of shares (358,495 units at $3.06) and sold $80,803 worth of shares (22,776 units at $3.55) (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 255d
  Chief Commercial Officer Grow Brian exercised 4,060 shares at a strike of $2.47 and covered exercise/tax liability with 2,173 shares, increasing direct ownership by 0.28% to 672,377 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 281d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 360 shares, decreasing direct ownership by 0.19% to 189,165 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 323d
  Chief Admin. and Legal Officer Freedman Lori bought $725,290 worth of shares (252,264 units at $2.88), increasing direct ownership by 42% to 846,459 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 409d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 271 shares, decreasing direct ownership by 0.14% to 189,525 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 415d
  Director Driscoll Michael Joseph sold $127,535 worth of shares (25,000 units at $5.10), decreasing direct ownership by 13% to 166,879 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 417d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 667 shares, decreasing direct ownership by 0.35% to 189,796 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Vice President, Strategy Cavorsi Robert was granted 61,705 shares, increasing direct ownership by 48% to 190,463 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Chief Operating Officer Bilbo Patrick was granted 184,136 shares, increasing direct ownership by 24% to 949,062 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Vice President, Health Policy Montecalvo Antonio S. was granted 42,493 shares, increasing direct ownership by 28% to 196,680 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Chief Commercial Officer Grow Brian was granted 183,067 shares, increasing direct ownership by 38% to 670,490 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Chief Admin. and Legal Officer Freedman Lori was granted 162,047 shares, increasing direct ownership by 37% to 594,195 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Chief Financial Officer Francisco David was granted 165,156 shares, increasing direct ownership by 42% to 559,095 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Quintero Gilberto was granted 49,575 shares, increasing direct ownership by 35% to 190,245 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Lustig Garrett was granted 49,575 shares, increasing direct ownership by 181% to 76,914 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Leibowitz Arthur S was granted 49,575 shares, increasing direct ownership by 26% to 237,186 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Korfin Michele Ilene was granted 49,575 shares, increasing direct ownership by 35% to 190,245 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  President and CEO Gillheeney Gary S. was granted 708,215 shares, increasing direct ownership by 25% to 3,515,323 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Giacomin Jon L was granted 49,575 shares, increasing direct ownership by 35% to 192,198 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Duraibabu Prathyusha was granted 49,575 shares, increasing direct ownership by 33% to 198,219 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 428d
  Director Driscoll Michael Joseph was granted 49,575 shares, increasing direct ownership by 35% to 191,879 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Vice President, Strategy Cavorsi Robert covered exercise/tax liability with 11,008 shares, decreasing direct ownership by 8% to 128,758 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Vice President, Health Policy Montecalvo Antonio S. covered exercise/tax liability with 14,081 shares, decreasing direct ownership by 8% to 154,187 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  President and CEO Gillheeney Gary S. covered exercise/tax liability with 232,086 shares, decreasing direct ownership by 8% to 2,807,108 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Chief Commercial Officer Grow Brian covered exercise/tax liability with 33,386 shares, decreasing direct ownership by 6% to 487,423 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Chief Operating Officer Bilbo Patrick covered exercise/tax liability with 44,156 shares, decreasing direct ownership by 5% to 764,926 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Chief Admin. and Legal Officer Freedman Lori covered exercise/tax liability with 37,124 shares, decreasing direct ownership by 8% to 432,148 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 430d
  Chief Financial Officer Francisco David covered exercise/tax liability with 35,057 shares, decreasing direct ownership by 8% to 393,939 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 467d
  Director Ades Alan A. gifted 6,401,945 shares and received a gift of 12,803,890 shares, decreasing direct ownership by 11% to 51,085,402 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 467d
  Director Ades Alan A. gifted 6,401,945 shares and received a gift of 12,803,890 shares, decreasing direct ownership by 11% to 51,085,402 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 477d
  Director Ades Alan A. gifted 1,710,552 shares and received a gift of 3,421,104 shares, decreasing direct ownership by 3% to 51,085,403 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 477d
  Director Ades Alan A. gifted 1,710,552 shares and received a gift of 3,421,104 shares, decreasing direct ownership by 3% to 51,085,403 units (SEC Form 4)

  4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
• 477d
  SEC Form 3 filed by new insider Ades Josette

  3 - Organogenesis Holdings Inc. (0001661181) (Issuer)